One-Time gene shot aims to stop bleeding in hemophilia a
NCT ID NCT06833983
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a single-dose gene therapy called GS1191-0445 in 50 Chinese men with hemophilia A. The treatment uses a harmless virus to deliver a working gene to the liver, helping the body produce its own clotting factor. The goal is to reduce bleeding episodes and the need for regular factor infusions. Participants will be monitored for safety and effectiveness over one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Anhui Provincial Hospital
NOT_YET_RECRUITINGHefei, Anhui, 230001, China
-
Central Hospital Affiliated to Shandong First Medical University
RECRUITINGJinan, Shandong, 250013, China
-
First Hospital of Lanzhou University
NOT_YET_RECRUITINGLanzhou, Gansu, 730099, China
-
Henan Cancer Hospital
NOT_YET_RECRUITINGZhengzhou, Henan, 450003, China
-
Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College
RECRUITINGTianjin, Tianjin Municipality, 300020, China
-
Jiangxi Provincial People's Hospital
NOT_YET_RECRUITINGNanchang, Jiangxi, 344001, China
-
Nanfang Hospital Southern Medical University
NOT_YET_RECRUITINGGuangzhou, Guangdong, 510515, China
-
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
NOT_YET_RECRUITINGNanjing, Jiangsu, 210000, China
-
North China University of Science and Technology Affiliated Hospital
NOT_YET_RECRUITINGTangshan, Hebei, 063000, China
-
Peking Union Medical College Hospital
NOT_YET_RECRUITINGBeijing, Beijing Municipality, 100005, China
-
The second Affiliated Hospital of Kunming Medical University
NOT_YET_RECRUITINGKunming, Yunnan, 650101, China
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
NOT_YET_RECRUITINGWuhan, Hubei, 430022, China
-
Xiangya Hospital of Central South University
NOT_YET_RECRUITINGChangsha, Hunan, 410028, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A Once-a-Week shot could transform hemophilia Care—Even for those with inhibitors
- Can a new clotting factor offer better bleed protection for severe hemophilia?
- Do newer hemophilia drugs protect joints better? study aims to find out
- Newborn screening study aims to catch rare diseases at birth
- Could home blood tests transform hemophilia care? study seeks patient views
- New clotting factor shows promise for hemophilia a bleeds